Press Release
November 14, 2022
Showing 1 - 10 of 78 results
Spotlight
October 10, 2024
From Awkward to Engaging: Toolkit Promotes Productive Conversations
Advance care planning is an essential part of post-acute and long-term care (PALTC). However, conversations with patients and family members about a serious illness, palliative care, and hospice can be stressful, challenging, and awkward. The Serious Illness Messaging Toolkit was created to ease the stress...
JAMDA
April 7, 2014
New Toolkit to Measure Quality of Person-Centered Care: Development and Pilot Evaluation With Nursing Home Communities
Increasingly, nursing home (NH) providers are adopting a person-centered care (PCC) philosophy; yet, they currently lack methods to measure their progress toward this goal. Few PCC tools meet criteria for ease of use and feasibility in NHs. The purpose of this article is to report on the development of the...
Policy Snapshot
March 15, 2024
Skilled Nursing Facilities: Billing Medicare for Respiratory Vaccines
Medicare pays for vaccines administered during a patient’s stay in a nursing home. Vaccine payment depends on the type of vaccine and whether the patient is using their Skilled Nursing Facility Part A benefit. Learn how to bill for a number of vaccines
Spotlight
November 2, 2023
Toolkit Helps Providers Develop Public Messaging about the Benefits of Advance Care Planning, Palliative Care, and Hospice
Policy Snapshot
December 15, 2023
Billing for Flu, Pneumococcal, and COVID-19 Vaccines
For flu, pneumococcal, and COVID-19 vaccines furnished on or after July 1, 2023, to patients staying in a Medicare Part A-covered skilled nursing facility (SNF), immunizers can no longer bill Medicare directly.
Policy Snapshot
May 31, 2024
Morbidity and Mortality Weekly Report — Early Safety Findings Among Persons Aged 60 Years and Older Who Received a Respiratory Syncytial Virus Vaccine — United States, May 3, 2023–April 14, 2024
A new Morbidity and Mortality Weekly Report (MMWR) highlights safety findings for two respiratory syncytial virus (RSV) vaccines licensed by the Food and Drug Administration (FDA) in May 2023 for adults 60 years of age and older.
JAMDA
July 20, 2021
Racial Disparities in COVID-19 Vaccine Acceptance: Building Trust to Protect Nursing Home Staff and Residents
Vaccines are critical to protect both nursing home residents and staff from COVID-19, but some staff have expressed reservations about being vaccinated. In this brief report, we describe interventions that Genesis HealthCare—one of the largest US long-term care providers—implemented after recognizing midwa...
JAMDA
February 15, 2019
Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season
Influenza is a leading cause of admissions for nursing home (NH) residents. We previously evaluated the effectiveness of a high-dose trivalent influenza vaccine (HD) compared to a standard-dose influenza vaccine (SD) through a cluster-randomized trial of NH residents. Fewer residents from facilities rando...
JAMDA
March 20, 2021